Skip to main content
AUTL logo
AUTL
(NASDAQ)
Autolus Therapeutics plc
$1.52-- (--)
Loading... - Market loading

Autolus Therapeutics (AUTL) Stock Price & Financial Analysis

Autolus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.41 - $1.54
52-Week High$2.70
52-Week Low$1.18
Open$1.42
Volume970.06K
Average Volume (3M)1.10M
Market Cap404.54M
Shares Outstanding266.14M
Price to Sales (P/S)4.37
Price to Book (P/B)3.72
EV/EBITDA-1.43
Revenue (TTM)92.62M
Net Income (TTM)-288.96M
Free Cash Flow (TTM)-311.45M
EPS (TTM)$-1.09
Profit Margin-311.98%
Operating Margin-285.91%
Return on Equity (ROE)-265.53%
Debt to Equity0.73
50-Day MA$1.59
200-Day MA$1.54
52-Week Change-43.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Autolus Therapeutics

What is the current stock price for AUTL?

As of the latest trading session, AUTL stock trades at $1.52. The 52-week range is $1.18–$2.70, with a day range of $1.41–$1.53.

What is the P/E ratio for AUTL?

The P/E ratio (Price-to-Earnings) for AUTL is shown in the Key Statistics section. This valuation metric helps compare Autolus Therapeutics plc to industry peers.

Does AUTL pay dividends?

Autolus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AUTL?

Based on 8 analysts, the consensus for AUTL is Buy.

What is the market cap of AUTL?

Autolus Therapeutics's market capitalization is $404.5M, classifying it as a small-cap company. Autolus Therapeutics operates in the Healthcare sector within the Biotechnology industry.